Biotech

All Articles

Metsera coordinate with Amneal to secure down GLP-1 source

.With early period 1 records now out in bush, metabolic disease outfit Metsera is actually throwing ...

Rivus posts records to back up muscle-sparing weight problems medication insurance claims

.Rivus Pharmaceuticals has actually introduced the data behind its stage 2 being overweight succeed ...

BMS pays out $110M to create T-cell therapy contract, assisting Best get opportunity to advance prioritized pipe

.Bristol Myers Squibb is actually paying Main Medication $110 million ahead of time to establish rea...

Generate increases an additional $1B-plus Large Pharma collaboration

.Novartis has inked an offer likely worth much more than $1 billion with Flagship-founded Generate: ...

Metsera GLP-1 data slice shows 7.5% weight loss at 36 days

.Recently debuted Metsera is actually unfolding some stage 1 data for its own GLP-1 receptor agonist...

Flagship wishes biotechs flock to Mirai to enhance genetic meds

.Amid the genetic medicines arms ethnicity, Main Pioneering is actually unveiling a new business to ...

BioAge eyes $180M coming from IPO, private positioning for weight problems trials

.BioAge Labs is looking at around $180 thousand in preliminary profits from an IPO as well as a priv...

Merck's LAG-3 combo falls short colorectal cancer phase 3 research study

.An effort by Merck &amp Co. to open the microsatellite secure (MSS) metastatic intestines cancer ma...

Spanish VC finalizes $200M lifestyle scientific researches fund

.Spain-based Asabys Partners has closed a fund of 180 thousand europeans ($ 200 million), funds that...

BioAge brings in $198M from IPO as being overweight biotech joins Nasdaq

.BioAge Labs is actually introducing nearly $200 million using its Nasdaq IPO today, along with the ...